# FDA Inspection 1274266 - Silliker Laboratories Group, Inc - June 30, 2025

Source: https://www.keypedia.com/records/fda_inspections/silliker-laboratories-group-inc/65cb4ce8-3065-4706-82b4-7d54578fb8d2
Source feed: FDA_Inspections

> FDA Inspection 1274266 for Silliker Laboratories Group, Inc on June 30, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274266
- Company Name: Silliker Laboratories Group, Inc
- Inspection Date: 2025-06-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1008205 - 2017-03-07](https://www.keypedia.com/records/fda_inspections/silliker-laboratories-group-inc/8cb839c6-feb3-405b-b704-25a4bf08373c)
- [FDA Inspection 751480 - 2011-10-12](https://www.keypedia.com/records/fda_inspections/silliker-laboratories-group-inc/1fa0ce48-8626-4011-8d8b-a78ece7c831c)
- [FDA Inspection 710450 - 2011-02-07](https://www.keypedia.com/records/fda_inspections/silliker-laboratories-group-inc/164de344-f5a2-4a28-ad19-2b59892e6c0d)
- [FDA Inspection 663124 - 2010-05-20](https://www.keypedia.com/records/fda_inspections/silliker-laboratories-group-inc/f1b418c0-88ae-4a80-9dd3-a83dba31e445)

Company: https://www.keypedia.com/companies/silliker-laboratories-group-inc/a9d53aca-972c-488b-a699-d41cdadcf067

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b